A Price File Is Not a Purchasing Strategy
Healthcare price information is becoming more available. That is useful. It is not the same thing as having a purchasing strategy.
For a self-funded employer, a large price file can create a false sense of progress. The file may contain a lot of rates, but a CEO or CFO still needs to decide what question to ask, which care matters most, what comparison is fair, and who is responsible for acting on the answer. Without that discipline, more data can simply mean more noise.
The source idea: price disclosures must become more usable
In an October 2026 fact sheet, the Centers for Medicare & Medicaid Services described final changes intended to improve the accessibility, standardization, and reliability of Transparency in Coverage disclosures. The underlying rules already require non-grandfathered group health plans and issuers to post machine-readable files, including in-network rates, out-of-network allowed amounts, and prescription-drug information.
That is an important direction for employers. Better disclosures can make a comparison more possible. They do not, by themselves, establish whether a rate is relevant to your population, whether the benefit design is comparable, or whether a change would improve care or total plan cost.
Begin with the spend you can influence
A practical purchasing discussion rarely starts with every service in a file. It starts with the part of spend that is both material and actionable. A Midwest employer may want to understand a local hospital system, a set of common imaging services, a high-cost infusion category, or a pharmacy class that is moving the budget.
Then the team needs a clean question. Are we comparing a contracted rate, an allowed amount, a bundled quote, or actual paid claims? Is the service described the same way across providers? Is the location reasonably accessible for employees? Does a lower unit price create a different downstream cost or disruption? A comparison without those guardrails can look precise while pointing to the wrong decision.
Make the file part of a repeatable process
Good purchasing is less about finding a single surprising number and more about building a dependable review habit. The employer should be able to identify the data source, the service or category under review, the decision owner, the operational constraints, and the evidence that would justify a change. That record gives leadership a way to revisit the choice when contracts, networks, or utilization change.
It also gives vendors a clearer assignment. A third-party administrator, network, PBM, consultant, or direct-contracting partner may help gather and interpret information. The employer still needs to know who will answer the business question, by when, and how the conclusion will be tested against plan results.
Data access is an operating issue
For Paul H. Flowers Jr. at Superior Insurance Advisors and Paul.Health, transparency is most valuable when it supports a decision the employer can explain in plain English. That might be a request for a focused provider comparison, a contract question before renewal, a review of a pharmacy category, or a discussion about whether direct contracting is worth evaluating.
The point is not to promise that a public file will produce savings. The point is to help the employer move from “we have data” to “we have a documented reason for the next step.”
Source: Centers for Medicare & Medicaid Services, “Transparency in Coverage Final Rules (CMS-9882-F)”, October 5, 2026. This article is original educational commentary, not legal, tax, investment, or fiduciary advice. Plan documents, contracts, and applicable law govern.
Five questions before treating price data as a recommendation
- What specific purchasing or plan-management decision are we trying to improve?
- Which service, provider, or pharmacy category is material enough to review first?
- Are we comparing like-for-like services, locations, and benefit conditions?
- What claims, utilization, access, or quality information should sit beside the price?
- Who owns the recommendation, the vendor follow-up, and the review of actual results?
At the next benefits meeting, can your team name the one purchasing question your available data is supposed to help answer?